R. Matthew Gladden

6.3k citations

32 papers · 4.9k indexed · 9 hit papers · h-index 21

Public Health, Environmental and Occupational Health top 0.2%
Epidemiology top 2%
Anesthesiology and Pain Medicine top 0.2%
Pediatrics, Perinatology and Child Health top 1%
Emergency Medicine top 0.5%

Co-authors: Jon E. Zibbell Rose A. Rudd Puja Seth Julie O’Donnell Alana M. Vivolo‐Kantor Christine L. Mattson Christopher M. Jones Pedro Daniel Martínez
Topics: Opioid Use Disorder Treatment (22 papers)Poisoning and overdose treatments (10 papers)Pain Management and Opioid Use (9 papers)
Cited by: Toxicology Anesthesiology and Pain Medicine Public Health, Environmental and Occupational Health
Journals: American Journal of Public Health American Journal of Transplantation Drug and Alcohol Dependence
Partner nations: United States Tanzania India

In The Last Decade

R. Matthew Gladden

31 papers receiving 4.7k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Increases in Drug and Opioid Overdose Deaths — United States, 2000–2014

2015 1.5k citations R. Matthew Gladden et al. MMWR Morbidity and Mortality Weekly Report profile →
Bullying surveillance among youths : uniform definitions for public health and recommended data elements, Version 1.0

2014 456 citations R. Matthew Gladden, Alana M. Vivolo‐Kantor et al. profile →
Vital Signs: Demographic and Substance Use Trends Among Heroin Users - United States, 2002-2013.

2015 389 citations Christopher M. Jones, Joseph E. Logan et al. PubMed profile →
Fentanyl Law Enforcement Submissions and Increases in Synthetic Opioid–Involved Overdose Deaths — 27 States, 2013–2014

2016 338 citations R. Matthew Gladden, Pedro Daniel Martínez et al. MMWR Morbidity and Mortality Weekly Report profile →
Vital Signs: Trends in Emergency Department Visits for Suspected Opioid Overdoses — United States, July 2016–September 2017

2018 312 citations Alana M. Vivolo‐Kantor, Puja Seth et al. MMWR Morbidity and Mortality Weekly Report profile →
Deaths Involving Fentanyl, Fentanyl Analogs, and U-47700 — 10 States, July–December 2016

2017 312 citations Julie O’Donnell, John Halpin et al. MMWR Morbidity and Mortality Weekly Report profile →
Increases in Drug and Opioid Overdose Deaths—United States, 2000–2014

2016 260 citations R. Matthew Gladden et al. profile →
Trends in Deaths Involving Heroin and Synthetic Opioids Excluding Methadone, and Law Enforcement Drug Product Reports, by Census Region — United States, 2006–2015

2017 242 citations Julie O’Donnell, R. Matthew Gladden et al. MMWR Morbidity and Mortality Weekly Report profile →
Characteristics of Fentanyl Overdose — Massachusetts, 2014–2016

2017 231 citations Julie O’Donnell, R. Matthew Gladden et al. MMWR Morbidity and Mortality Weekly Report profile →

Peers

Countries citing papers authored by R. Matthew Gladden

Since Specialization

Citations

This map shows the geographic impact of R. Matthew Gladden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Matthew Gladden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Matthew Gladden more than expected).

Fields of papers citing papers by R. Matthew Gladden

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Matthew Gladden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Matthew Gladden. The network helps show where R. Matthew Gladden may publish in the future.

Co-authorship network of co-authors of R. Matthew Gladden

This figure shows the co-authorship network connecting the top 25 collaborators of R. Matthew Gladden. A scholar is included among the top collaborators of R. Matthew Gladden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Matthew Gladden. R. Matthew Gladden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Public Health Interventions and Overdose-Related Outcomes Among Persons With Opioid Use Disorder 2024 ·JAMA Network Open ·Nisha Nataraj,S. Michaela Rikard,Kun Zhang,Xinyi Jiang,Gery P. Guy,Ketra Rice,Christine L. Mattson,R. Matthew Gladden,Desiree Mustaquim,(unknown),Puja Seth,Rita K. Noonan,Jan L. Losby	8
2	Notes from the Field: Geo-Temporal Trends in Fentanyl Administration Routes Among Adults Reporting Use of Illegally Manufactured Fentanyl When Assessed for Substance-Use Treatment — 14 U.S. States, 2017–2023 2024 ·MMWR Morbidity and Mortality Weekly Report ·(unknown),Xinyi Jiang,R. Matthew Gladden,Nisha Nataraj,Gery P. Guy,Deborah Dowell	1
3	Suspected Counterfeit M-30 Oxycodone Pill Exposures and Acute Withdrawals Reported from a Single Hospital — Toxicology Investigators Consortium Core Registry, U.S. Census Bureau Western Region, 2017–2022 2024 ·MMWR Morbidity and Mortality Weekly Report ·Emily Glidden,R. Matthew Gladden,(unknown),Meghan B. Spyres,Puja Seth,Kim Aldy,Desiree Mustaquim	3
4	Detection of emerging drugs involved in overdose via diachronic word embeddings of substances discussed on social media 2021 ·Journal of Biomedical Informatics ·(unknown),Christopher M. Jones,Duen Horng Chau,R. Matthew Gladden,Steven A. Sumner	15
5	Defining indicators for drug overdose emergency department visits and hospitalisations in ICD-10-CM coded discharge data 2021 ·Injury Prevention ·Alana M. Vivolo‐Kantor,(unknown),Stephen V. Liu,Pedro Daniel Martínez,R. Matthew Gladden	35
6	Perceptions of Diseases of Despair by Members of Rural and Urban High-Prevalence Communities 2021 ·JAMA Network Open ·Daniel R. George,Bethany Snyder,Lauren J. Van Scoy,Emily Brignone,Lawrence I. Sinoway,Charity L. Sauder,(unknown),R. Matthew Gladden,(unknown),(unknown),(unknown),(unknown),Jennifer L. Kraschnewski	18
7	Notes from the Field: Testing for Nonprescribed Fentanyl and Percentage of Positive Test Results Among Patients with Opioid Use Disorder — United States, 2019–2020 2021 ·MMWR Morbidity and Mortality Weekly Report ·Justin K. Niles,Jeffrey Gudin,Alana M. Vivolo‐Kantor,R. Matthew Gladden,Desiree Mustaquim,Puja Seth,Harvey W. Kaufman	3
8	Trends in the diagnosis of diseases of despair in the United States, 2009–2018: a retrospective cohort study 2020 ·BMJ Open ·Emily Brignone,Daniel R. George,Lawrence I. Sinoway,Curren Katz,Charity L. Sauder,(unknown),R. Matthew Gladden,Jennifer L. Kraschnewski	32
9	Carfentanil Outbreak — Florida, 2016–2017 2020 ·MMWR Morbidity and Mortality Weekly Report ·Chris Delcher,Yanning Wang,(unknown),John Halpin,R. Matthew Gladden,Julie O’Donnell,(unknown),Bruce A. Goldberger	33
10	Notes from the Field: Fentanyl Drug Submissions — United States, 2010–2017 2019 ·MMWR Morbidity and Mortality Weekly Report ·Yuri P. Springer,R. Matthew Gladden,Julie O’Donnell,Puja Seth	13
11	Notes from the Field: Overdose Deaths with Carfentanil and Other Fentanyl Analogs Detected — 10 States, July 2016–June 2017 2018 ·MMWR Morbidity and Mortality Weekly Report ·Julie O’Donnell,R. Matthew Gladden,Christine L. Mattson,Mbabazi Kariisa	76
12	Increases in prescription opioid injection abuse among treatment admissions in the United States, 2004–2013 2017 ·Drug and Alcohol Dependence ·Christopher M. Jones,Aleta Christensen,R. Matthew Gladden	61
13	Deaths Involving Fentanyl, Fentanyl Analogs, and U-47700 — 10 States, July–December 2016breakdown → 2017 ·MMWR Morbidity and Mortality Weekly Report ·Julie O’Donnell,John Halpin,Christine L. Mattson,Bruce A. Goldberger,R. Matthew Gladden	312
14	Opioid Overdose Outbreak — West Virginia, August 2016 2017 ·MMWR Morbidity and Mortality Weekly Report ·(unknown),Michael E. Kilkenny,(unknown),(unknown),(unknown),John Halpin,R. Matthew Gladden,Danae Bixler,Loretta Haddy,(unknown)	22
15	Trends in Deaths Involving Heroin and Synthetic Opioids Excluding Methadone, and Law Enforcement Drug Product Reports, by Census Region — United States, 2006–2015breakdown → 2017 ·MMWR Morbidity and Mortality Weekly Report ·Julie O’Donnell,R. Matthew Gladden,Puja Seth	242
16	Vital Signs: Demographic and Substance Use Trends Among Heroin Users - United States, 2002-2013.breakdown → 2015 ·PubMed ·Christopher M. Jones,Joseph E. Logan,R. Matthew Gladden,Michele K. Bohm	389
17	Increase in Suicides Associated With Home Eviction and Foreclosure During the US Housing Crisis: Findings From 16 National Violent Death Reporting System States, 2005–2010 2014 ·American Journal of Public Health ·Katherine A. Fowler,R. Matthew Gladden,Kevin J. Vagi,(unknown),Leroy Frazier	113
18	Surveillance for violent deaths - National Violent Death Reporting System, 16 states, 2010. 2014 ·PubMed ·Sharyn E. Parks,(unknown),Dawn McDaniel,R. Matthew Gladden	62
19	Changing Special Education Enrollments: Causes and Distribution among Schools. The State of Chicago Public High Schools: 1993 to 2000. 2002 ·Shazia Rafiullah Miller,R. Matthew Gladden	1
20	Chapter 6:Reducing School Violence: Strengthening Student Programs and Addressing the Role of School Organizations 2002 ·Review of Research in Education ·R. Matthew Gladden	29

About R. Matthew Gladden

R. Matthew Gladden is a scholar working on Anesthesiology and Pain Medicine, Toxicology and Emergency Medicine, having authored 32 papers that have together received 4.9k indexed citations. Recurring topics across this work include Opioid Use Disorder Treatment (22 papers), Poisoning and overdose treatments (10 papers) and Pain Management and Opioid Use (9 papers). The work is most often cited by research in Toxicology (704 citations), Anesthesiology and Pain Medicine (973 citations) and Public Health, Environmental and Occupational Health (3.2k citations). R. Matthew Gladden has collaborated with scholars based in United States, Tanzania and India. Frequent co-authors include Jon E. Zibbell, Rose A. Rudd, Puja Seth, Julie O’Donnell, Alana M. Vivolo‐Kantor, Christine L. Mattson, Christopher M. Jones, Pedro Daniel Martínez, Merle E. Hamburger and Michele K. Bohm. Their work appears in journals such as American Journal of Public Health, American Journal of Transplantation and Drug and Alcohol Dependence.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact